China Life(601628)
Search documents
全球大公司要闻 | SpaceX冲刺万亿IPO,谷歌Meta败诉
Wind万得· 2026-03-26 01:16
Group 1 - SpaceX is preparing for its largest IPO, planning to submit confidential documents to regulators soon, with a target valuation of $1.75 trillion and expected fundraising of $50 billion to $75 billion [2] - OpenAI will shut down its Sora video generation service and terminate its partnership with Disney to streamline its AI product line [3] - Pop Mart's revenue for 2025 is projected to reach 37.12 billion yuan, a year-on-year increase of 184.7%, with adjusted net profit expected to be 13.08 billion yuan, up 284.5% [3] - Pinduoduo's Q4 2025 revenue is expected to be 123.91 billion yuan, a 12% year-on-year increase, while adjusted net profit is projected to decline by 12% [4] - Meta faces a lawsuit regarding social media addiction, with a ruling requiring it to pay 70% of damages, and plans to lay off hundreds of employees [4] Group 2 - China Life achieved a revenue of 615.68 billion yuan in 2025, a 16.5% year-on-year increase, with a net profit of 154.08 billion yuan, up 44.1% [6] - China Eastern Airlines signed a purchase agreement for 101 A320NEO aircraft with a catalog price of approximately $15.802 billion [7] - Zijin Mining reported a 62% increase in net profit for 2025, marking a historical high [7] - Alibaba Health partnered with Novartis to provide integrated services for chronic spontaneous urticaria [7] - BASF announced price increases for its commodity amines portfolio in Europe, with increases potentially reaching 30% due to rising costs from geopolitical tensions [16]
中国人寿(02628) - 2025 H2 - 电话会议演示
2026-03-26 01:00
Annual Results 26 March 2026 | Beijing • Hong Kong FORWARD LOOKING STATEMENT Certain statements contained in this presentation may be viewed as "forward-looking statements". These forward-looking statements state our intentions, beliefs, expectations or predictions for the future; and in some cases, we use words such as "believe", "intend", "anticipate", "estimate", "project", "forecast", "plan", "potential", "will", "may", "should" and "expect" and similar expressions to identify forward-looking statements ...
中国人寿(601628):净利润高增驱动DPS增长,NBV延续向好
Guolian Minsheng Securities· 2026-03-25 15:25
Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of the company [3] Core Views - The company achieved a net profit of 154.08 billion yuan in 2025, representing a year-on-year increase of 44.1%. The new business value (NBV) was 45.75 billion yuan, up 35.7% year-on-year, with a proposed dividend per share of 0.856 yuan, an increase of 31.7% [1][9] - The company’s investment assets reached 7.42 trillion yuan by the end of 2025, showing a growth of 12.3% compared to the end of 2024. The proportion of core secondary equity assets has significantly increased [9] - The company’s total investment return rate for 2025 was 6.09%, an increase of 0.59 percentage points year-on-year, with net investment income of 193.8 billion yuan, a decrease of 1.0% year-on-year [9] Financial Forecasts - For 2026, the company is expected to achieve a net profit of 119.84 billion yuan, a decrease of 22.2% year-on-year, followed by a recovery with projected profits of 132.32 billion yuan in 2027 and 144.54 billion yuan in 2028 [2][10] - The estimated earnings per share (EPS) for 2026 is 4.2 yuan, with a projected increase to 4.7 yuan in 2027 and 5.1 yuan in 2028 [2] - The estimated enterprise value per share (EVPS) is projected to be 54.3 yuan in 2026, increasing to 56.6 yuan in 2027 and 58.8 yuan in 2028 [2] Business Performance - The company’s NBV from individual insurance and bancassurance channels reached 39.30 billion yuan and 6.45 billion yuan respectively, with year-on-year growth of 25.5% and 169.3% [9] - The new single premium income increased by 9.3% year-on-year to 234.08 billion yuan, with the NBV margin rising by 3.8 percentage points to 19.5% [9] - The company’s first-year regular premium income from floating income products accounted for nearly 50% of the total, indicating a successful transformation in product offerings [9]
创新高!中国人寿2025年盈利超1540亿元!投资收益大幅提高
券商中国· 2026-03-25 14:54
A股上市险企首份2025年年报出炉。3月25日晚间,中国人寿公布的业绩报告显示,2025年实现归母净利润 1540.78亿元,继续创新高,同比增长44.1%。 中国人寿表示,公司重视与投资者共享高质量发展成果,董事会建议派发2025年末期现金股息每10股6.18元 (含税),连同已派发的2025年中期现金股息,全年累计派息每10股8.56元(含税),分红总额达241.95亿 元,同比提升31.7%。 对于2025年盈利在高基数上继续实现大幅增长,中国人寿将原因解释为"公司持续深化资产负债联动,深入推 进产品和业务多元,科学管控负债成本,持续提升投入产出效能,同时动态优化大类资产配置,投资收益大幅 提高。" 年报显示,2025年,中国人寿实现总投资收益3876.94亿元,较2024年同期增加794.43亿元,增幅为25.8%。投 资收益增加,主要源自"投资资产规模增加及主动投资操作"。 中国人寿2025年总投资收益率为6.09%,较2024年同期上升59个基点。无论从保险行业还是中国人寿自身看, 这一投资业绩都属近年上佳表现。券商中国记者据Wind数据统计,6.09%的总投资收益率,是中国人寿2007年 A股上 ...
今日晚间重要公告抢先看——罗博特科签订纳斯达克上市的F公司及其子公司6亿硅光订单;中国东航千亿购机计划正式落地;华工科技25年净利润同比增长20%
Jin Rong Jie· 2026-03-25 13:01
Group 1 - Robotech signed a significant contract worth approximately 600 million yuan for mass production coupling equipment and services applicable to pluggable silicon photonics technology, which is expected to positively impact the company's performance in 2026 [2] - China Eastern Airlines plans to purchase 101 Airbus A320NEO series aircraft at a catalog price totaling about 158.02 million USD, equivalent to approximately 108.93 billion yuan, with deliveries scheduled between 2028 and 2032 [2] - Huagong Technology projected a 20% year-on-year increase in net profit for 2025, with a proposed cash dividend of 2.5 yuan per 10 shares [18] Group 2 - Huadian Technology signed a 740 million yuan EPC contract for an offshore wind power project, with the company responsible for 693 million yuan of the contract amount [3] - Yahua Group signed a five-year lithium spodumene concentrate procurement agreement, ensuring a stable supply of resources for lithium salt product production [4] - China Life Insurance plans to invest 2.8 billion yuan in the Xinxin Technology Innovation Fund, focusing on private equity secondary markets and technology innovation sectors [6] Group 3 - Ruineng Technology is planning to acquire control of Botai Intelligent through a combination of issuing A-shares and cash payments, with stock suspension starting March 26 [8] - Debon Holdings will terminate its listing on the Shanghai Stock Exchange on March 31, 2026, after receiving approval for voluntary withdrawal [9] - New Yellow River announced the resignation of Chairman Zhao Zhengrong due to personal health reasons, with no adverse impact on the company's operations [10] Group 4 - Jiahua Food intends to invest approximately 1 billion yuan in a smart manufacturing project for super plant-based milk [11] - Xiamen Tungsten plans to acquire a stake in Jiangxi Jutong to enhance its tungsten resource self-sufficiency [12] - Energy Wind Power announced the resignation of its director and general manager Yang Zhongxu, with a smooth transition of responsibilities [13] Group 5 - Zhongtai Engineering reported a new contract amount of 18.964 billion yuan for January-February 2026, reflecting a year-on-year growth of 0.54% [26] - Jinli Permanent Magnet reported a 142.44% year-on-year increase in net profit for 2025, with a proposed cash dividend of 2.2 yuan per 10 shares [27] - Noya New Materials reported a 337.6% year-on-year increase in net profit for 2025, with a proposed cash dividend of 3.2 yuan per 10 shares [23]
A股公告精选 | 总价超千亿!中国东航(600115.SH)将向空客购买101架飞机
智通财经网· 2026-03-25 11:46
Group 1 - China Eastern Airlines plans to purchase 101 A320NEO aircraft from Airbus, with a total list price of approximately 158.02 billion USD, equivalent to about 108.93 billion RMB based on the exchange rate at the time of the agreement [1] Group 2 - China Life intends to invest 2.8 billion RMB to establish a venture capital fund in collaboration with the Fujian government and others, focusing on strategic emerging industries such as new generation information technology and biomedicine [2] Group 3 - Debon Logistics will voluntarily delist its shares from the Shanghai Stock Exchange, with the delisting effective on March 31, 2026 [3] Group 4 - Hangzhou Dianzi plans to reduce its shareholding by up to 0.89%, with specific reductions planned by major shareholders and executives [4] Group 5 - Ruineng Technology is planning to acquire up to 75% of Botai Intelligent Equipment to gain control, with the stock expected to be suspended for trading starting March 26, 2026 [5] Group 6 - Hengtong Group's subsidiary plans to invest up to 500 million RMB in a composite foil project, aiming for an annual production capacity of 45 million square meters of high-end copper-aluminum composite foil [6] Group 7 - Jinli Permanent Magnet reported a net profit of 706 million RMB for 2025, a year-on-year increase of 142% [7] - China Life reported a net profit of 154.08 billion RMB for 2025, a year-on-year increase of 44% [11] - China General Nuclear Power reported a net profit of 9.765 billion RMB for 2025, a year-on-year decrease of 9.9% [11]
中国人寿(601628) - 中国人寿H股公告

2026-03-25 11:15
1. 提名薪酬委員會是公司董事會專門委員會,負責檢討董事會架構、人數和組 成,擬定董事、高級管理人員的選擇標準和程序,對董事、高級管理人員人選 及其任職資格進行遴選、審核,制定董事、高級管理人員的考核標準、薪酬政 策、培訓計劃等,以及檢討董事會及公司多元化政策。 2. 提名薪酬委員會由 3-7 名不在公司擔任高級管理人員的董事組成,其中獨立董 事應當過半數並擔任主席(主任委員)。 3. 提名薪酬委員會就下列事項向董事會提出建議: (a) 提名或者任免董事,聘任或者解聘高級管理人員; (b) 董事、高級管理人員的考核標準及結果; (c) 董事、高級管理人員的薪酬,包括研究及審查董事及高級管理人員的薪 酬政策、方案及架構,就設立正規而具透明度的程序制訂薪酬政策,根 據企業方針及目標檢討和批准董事及高級管理人員的薪酬建議,同時確 保任何董事及其聯繫人不得參與釐定其本身的薪酬; (d) 根據董事會的授權,釐定執行董事及高級管理人員的薪酬待遇,薪酬包 括非金錢利益、退休金權利及賠償金額(包括喪失或終止職務或委任的 賠償),提名薪酬委員會應考慮的因素包括同類公司支付的薪酬、須付 出的時間及職責以及集團內其他職位的僱用條件 ...
中国人寿(02628) - 截至2025年12月31日止年度的末期股息

2026-03-25 10:46
EF001 EF001 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 中國人壽保險股份有限公司 | | 股份代號 | 02628 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2025年12月31日止年度的末期股息 | | 公告日期 | 2026年3月25日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年12月31日 | | 宣派股息 | 每 股 0.618 RMB | | 股東批准日期 | 2026年6月25日 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | HKD, 金額有待公佈 | | 匯率 | 有待公佈 | | ...
中国人寿(02628) - 中国人寿保险股份有限公司董事会提名薪酬委员会职权范围

2026-03-25 10:43
中國人壽保險股份有限公司董事會 提名薪酬委員會職權範圍 1. 提名薪酬委員會是公司董事會專門委員會,負責檢討董事會架構、人數和組 成,擬定董事、高級管理人員的選擇標準和程序,對董事、高級管理人員人選 及其任職資格進行遴選、審核,制定董事、高級管理人員的考核標準、薪酬政 策、培訓計劃等,以及檢討董事會及公司多元化政策。 2. 提名薪酬委員會由 3-7 名不在公司擔任高級管理人員的董事組成,其中獨立董 事應當過半數並擔任主席(主任委員)。 3. 提名薪酬委員會就下列事項向董事會提出建議: (a) 提名或者任免董事,聘任或者解聘高級管理人員; (b) 董事、高級管理人員的考核標準及結果; (c) 董事、高級管理人員的薪酬,包括研究及審查董事及高級管理人員的薪 酬政策、方案及架構,就設立正規而具透明度的程序制訂薪酬政策,根 據企業方針及目標檢討和批准董事及高級管理人員的薪酬建議,同時確 保任何董事及其聯繫人不得參與釐定其本身的薪酬; (d) 根據董事會的授權,釐定執行董事及高級管理人員的薪酬待遇,薪酬包 括非金錢利益、退休金權利及賠償金額(包括喪失或終止職務或委任的 賠償),提名薪酬委員會應考慮的因素包括同類公司支付 ...
中国人寿(02628) - 中国人寿保险股份有限公司董事会提名薪酬委员会职权范围

2026-03-25 10:41
中國人壽保險股份有限公司董事會 提名薪酬委員會職權範圍 (a) 檢討董事會的架構、人數、組成及成員多元化,包括但不限於性別、年 齡、文化及教育背景、技能、知識及專業經驗等,協助董事會編製董事 會技能表,並就任何為配合公司的經營策略而擬對董事會作出的變動提 出建議; (b) 物色具備合適資格可擔任董事的人士,並挑選提名有關人士出任董事或 就此向董事會提供意見;在物色合適人選時,應考慮有關人選的長處, 並以客觀條件充分顧及董事會成員多元化的裨益; (c) 檢討董事會為執行董事會成員多元化政策而制定的可計量目標和達標進 度,以及每年在《企業管治報告》內披露檢討結果。 6. 提名薪酬委員會應檢討及批准向執行董事及高級管理人員就其喪失或終止職務 或委任而須支付的賠償,以確保該等賠償與有關合約條款一致;若未能與合約 條款一致,賠償亦須公平合理,不會對公司造成過重負擔。 7. 提名薪酬委員會應檢討及批准因董事行為失當而解僱或罷免有關董事所涉及的 賠償安排,以確保該等安排與有關合約條款一致;若未能與有關合約條款一 致,有關賠償亦須合理適當。 8. 提名薪酬委員會應獲得充足的資源以履行其職責,可就公司薪酬管理體系對風 險、合規 ...